Business
C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient
C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient
About this update from C-rad Ab Class B
C-RAD AB (publ) the global leader in surface-guided radiation therapy (SGRT), and SeeTreat Pty Ltd, a pioneer in the adaptive decision support radiotherapy (ART) software, today announced a partnership to bring more connected, intelligent, and patient-centric radiotherapy workflows.The collaboration brings together two complementary technologies: C-RAD’s Catalyst⁺ HD platform, which provides patient setup and real-time motion monitoring, and SeeTreat’s ART.1, which delivers automated adaptive plan decision support for every patient at every treatment. Together, the two platforms span the complete radiotherapy session — from the moment the patient enters the room to the clinical decision about whether their treatment plan remains optimal.The partnership responds to a growing clinical demand for radiotherapy workflows that are not only more accurate and precise, but also faster, safer, and more personalised. Catalyst⁺ HD and ART.1 address different but deeply connected stages of every treatment session. By exploring how these two platforms can work in concert, C-RAD and SeeTreat aim to support clinical teams in making faster, better-informed decisions to improve patient care. Both companies share a commitment to bringing advances to radiotherapy departments of all sizes and any treatment machines — from major cancer centres to community clinics where resources may be limited, but the need for precision and efficiency is just as critical."This partnership opens an exciting new frontier in personalised cancer care. Catalyst⁺ HD gives clinical teams unmatched real-time visibility of the patient, and we believe combining this with SeeTreat’s intelligent adaptive decision support has the power to transform reactive oversight into confident, real-time clinical decision-making, every single fraction." shares Chief Product & Technology Officer, Dr Eeva-Liisa Karjalainen.“C-RAD has set the global benchmark for Surface Guided Radiation Therapy, and their focus on user-friendly, patient-centric technology aligns strongly with our own values at SeeTreat. This partnership is a significant step toward our shared vision of making personalised radiotherapy accessible for every patient in every clinic.” said CEO and Founder of SeeTreat, Dr Trang Nguyen.The companies will collaborate to explore clinical needs and product development opportunities that benefit clinicians and ...